GSEA on these differentially expressed genes showed pathways consistent with the defined SLE signature, with enriched pathways of interferon response, TNFa Signaling via NFkB, and inflammatory response in participants with active clinical disease (Fig. 5C). This evidence concerns the gene TNF and systemic lupus erythematosus.